{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:31Z","timestamp":1778803231166,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.canep.2024.102575","type":"journal-article","created":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T03:25:52Z","timestamp":1713929152000},"page":"102575","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Uveal melanoma incidence and survival analysis in Portugal between 2013 and 2022"],"prefix":"10.1016","volume":"90","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6851-6201","authenticated-orcid":false,"given":"Sara","family":"Geada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Telma","family":"Machado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T\u00e2nia","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo C\u00e9sar","family":"Sim\u00f5es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e1rbara","family":"Oliveiros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"da Luz Cachulo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Proen\u00e7a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.canep.2024.102575_bib1","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1002\/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-G","article-title":"The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society","volume":"83","author":"Chang","year":"1998","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.canep.2024.102575_bib2","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/cncr.20866","article-title":"Incidence of noncutaneous melanomas in the U.S","volume":"103","author":"McLaughlin","year":"2005","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.canep.2024.102575_bib3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000480640","article-title":"Uveal melanoma: 5-year update on incidence, treatment, and survival (SEER 1973\u20132013)","volume":"4","author":"Aronow","year":"2018","journal-title":"Ocul. Oncol. Pathol."},{"key":"10.1016\/j.canep.2024.102575_bib4","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2147\/OPTH.S89591","article-title":"Uveal melanoma: epidemiology, etiology, and treatment of primary disease","volume":"11","author":"Krantz","year":"2017","journal-title":"Clin. Ophthalmol."},{"issue":"7","key":"10.1016\/j.canep.2024.102575_bib5","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/IAE.0b013e31824d09a8","article-title":"Clinical spectrum and prognosis of uveal melanoma based on age at presentation in 8,033 cases","volume":"32","author":"Shields","year":"2012","journal-title":"Retina"},{"key":"10.1016\/j.canep.2024.102575_bib6","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/eye.2016.275","article-title":"Uveal melanoma: relatively rare but deadly cancer","volume":"31","author":"Kaliki","year":"2017","journal-title":"Eye"},{"key":"10.1016\/j.canep.2024.102575_bib7","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1016\/j.ophtha.2007.01.032","article-title":"EUROCARE Working Group et al. Incidence of uveal melanoma in Europe","volume":"114","author":"Virgili","year":"2007","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.canep.2024.102575_bib8","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1167\/iovs.15-16532","article-title":"Nationwide incidence of ocular melanoma in South Korea by Using the National Cancer Registry Database (1999\u20132011)","volume":"56","author":"Park","year":"2015","journal-title":"Invest Ophthalmol. Vis. Sci."},{"issue":"9","key":"10.1016\/j.canep.2024.102575_bib9","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.ophtha.2011.01.040","article-title":"Uveal melanoma: trends in incidence, treatment, and survival","volume":"118","author":"Singh","year":"2011","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.canep.2024.102575_bib10","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1136\/bjophthalmol-2015-306810","article-title":"Epidemiological trends in uveal melanoma","volume":"99","author":"Andreoli","year":"2015","journal-title":"Br. J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.canep.2024.102575_bib11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000492391","article-title":"Uveal melanoma in Ireland","volume":"5","author":"Baily","year":"2019","journal-title":"Ocul. Oncol. Pathol."},{"issue":"8","key":"10.1016\/j.canep.2024.102575_bib12","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1001\/archophthalmol.2009.208","article-title":"Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes","volume":"127","author":"Shields","year":"2009","journal-title":"Arch. Ophthalmol."},{"issue":"1","key":"10.1016\/j.canep.2024.102575_bib13","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ohc.2004.07.002","article-title":"Uveal melanoma: Epidemiologic aspects","volume":"18","author":"Singh","year":"2005","journal-title":"Ophthalmol. Clin. North Am."},{"issue":"1","key":"10.1016\/j.canep.2024.102575_bib14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s40942-020-00261-w","article-title":"Epidemiology of uveal melanoma in Brazil","volume":"6","author":"Lucena","year":"2020","journal-title":"Int J. Retin. Vitr."},{"issue":"8","key":"10.1016\/j.canep.2024.102575_bib15","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.ophtha.2012.01.048","article-title":"Detection and time to treatment of uveal melanoma in the United Kingdom: an evaluation of 2,384 patients","volume":"119","author":"Damato","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.canep.2024.102575_bib16","series-title":"AJCC Cancer Staging Manual","first-page":"805","article-title":"Uveal melanoma","author":"Kivel\u00e4","year":"2016"},{"issue":"2","key":"10.1016\/j.canep.2024.102575_bib17","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4103\/0301-4738.154367","article-title":"Uveal melanoma: estimating prognosis","volume":"63","author":"Kaliki","year":"2015","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.canep.2024.102575_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2022.101041","article-title":"Metastatic uveal melanoma: The final frontier","volume":"90","author":"Rantala","year":"2022","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.canep.2024.102575_bib19","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0002-9394(98)00039-7","article-title":"(COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma, II: initial mortality findings. COMS report No. 10","volume":"125","author":"The Collaborative Ocular Melanoma Study","year":"1998","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.canep.2024.102575_bib20","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/archopht.119.7.969","article-title":"The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: Initial mortality findings. COMS report No. 18","volume":"119","author":"Diener-West","year":"2001","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.canep.2024.102575_bib21","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1001\/archopht.1997.01100160056009","article-title":"Mortality in patients with small choroidal melanoma. COMS report No. 4","volume":"115","author":"The Collaborative Ocular Melanoma Study Group","year":"1997","journal-title":"Arch. Ophthalmol."},{"issue":"1","key":"10.1016\/j.canep.2024.102575_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brachy.2013.11.008","article-title":"The American Brachytherapy Society consensus guidelines for plaque brachytherapy of uveal melanoma and retinoblastoma","volume":"13","author":"Simpson","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.canep.2024.102575_bib23","first-page":"1791","article-title":"Global Incidence and Trend of Uveal Melanoma from 1943-2015: A Meta-Analysis","volume":"5","author":"Naseripour","year":"2023","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.canep.2024.102575_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.1001799","article-title":"Uveal melanoma incidence trends in Canada: 1992-2010 vs. 2011-2017","author":"Conte","year":"2023","journal-title":"Front. Med."},{"issue":"5","key":"10.1016\/j.canep.2024.102575_bib25","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1007\/s00417-021-05317-7","article-title":"The epidemiology of uveal melanoma in Germany: a nationwide report of incidence and survival between 2009 and 2015","volume":"260","author":"Alfaar","year":"2022","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"5","key":"10.1016\/j.canep.2024.102575_bib26","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0161-6420(03)00078-2","article-title":"Incidence of uveal melanoma in the United States: 1973\u20131997","volume":"110","author":"Singh","year":"2003","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.canep.2024.102575_bib27","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3109\/08820538.2016.1154176","article-title":"Disparities in Uveal Melanoma: patient Characteristics","volume":"31","author":"Nichols","year":"2016","journal-title":"Semin Ophthalmol."},{"key":"10.1016\/j.canep.2024.102575_bib28","first-page":"1","article-title":"Epidemiological Study of Uveal Melanoma from US Surveillance, Epidemiology, and End Results Program (2010\u20132015)","author":"Xu","year":"2020","journal-title":"J. Ophthalmol."},{"issue":"5","key":"10.1016\/j.canep.2024.102575_bib29","doi-asserted-by":"crossref","first-page":"453","DOI":"10.5114\/jcb.2017.70986","article-title":"Patterns of care and survival outcomes after treatment for uveal melanoma in the post-coms era (2004-2013): a surveillance, epidemiology, and end results analysis","volume":"9","author":"Rao","year":"2017","journal-title":"J. Conte Brachytherapy"},{"issue":"11","key":"10.1016\/j.canep.2024.102575_bib30","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1167\/iovs.03-0538","article-title":"Very long-term prognosis of patients with malignant uveal melanoma","volume":"44","author":"Kujala","year":"2003","journal-title":"Invest Ophthalmol. Vis. Sci."},{"issue":"4","key":"10.1016\/j.canep.2024.102575_bib31","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1001\/jamaophthalmol.2014.5395","article-title":"International Validation of the American Joint Committee on Cancer\u2019s 7th Edition Classification of Uveal Melanoma","volume":"133","author":"The AJCC Ophthalmic Oncology Task Force","year":"2015","journal-title":"JAMA Ophthalmol."},{"issue":"4","key":"10.1016\/j.canep.2024.102575_bib32","doi-asserted-by":"crossref","first-page":"303","DOI":"10.5114\/jcb.2020.98108","article-title":"Eye plaque brachytherapy versus enucleation for ocular melanoma: an analysis from the National Cancer Database","volume":"12","author":"Messer","year":"2020","journal-title":"J. Conte Brachytherapy"}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782124000547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782124000547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T11:53:47Z","timestamp":1715946827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877782124000547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":32,"alternative-id":["S1877782124000547"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2024.102575","relation":{},"ISSN":["1877-7821"],"issn-type":[{"value":"1877-7821","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uveal melanoma incidence and survival analysis in Portugal between 2013 and 2022","name":"articletitle","label":"Article Title"},{"value":"Cancer Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canep.2024.102575","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102575"}}